Keywords: Hepatitis C virus, Market forecasts, Decision Resources, Pipeline

Hepatitis C drug market forecast to more than triple to $7.5 billion by 2014, but decline thereafter

Article | 18 November 2010

As a result of the launch of several novel agents, the hepatitis C virus (HCV) drug market will more than ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in